Skip to main content
Figure 3 | BMC Nephrology

Figure 3

From: Extended dosing of darbepoetin alfa in peritoneal dialysis patients

Figure 3

Primary reasons for hospitalization during 12 months after conversion to darbepoetin alfa Q2W*. The primary reasons for hospitalization included infection (40.3%), and hyperkalemia/electrolyte disorders (25.7%), although most reasons for hospitalization were listed as 'other' (51.7%) *Calculated from the patients' who were hospitalized, the percentage who had at least one hospitalization for each reason. Note that more than one cause of hospitalization could be recorded for the same patient. Abbreviations: IHD, ischemic heart disease; CHF, chronic heart failure; PVD, peripheral vascular disease; Q2W, every 2 weeks.

Back to article page